Portland, OR -- (SBWire) -- 07/07/2017 --Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable to sequence DNA and RNA quickly and cheaply as compared to traditional technologies, such as Sanger sequencing. The studies conducted to determining the origin of life for all species and their evolution have become more challenging. In order to understand the organisms, the use of various next generation sequencing technologies is inevitable. Technological advancements present new pathways for the NGS services industry.
Early buyers will receive 20% customization on this report
The driving factors of the European NGS services market are faster and cost-efficient sequencing, rising preference of NGS over other platforms, and rising prevalence of inherited diseases. In addition, application of genomics in drug discovery, growing prevalence of cancer & other malignant diseases, and partnerships among companies, R&D centers, and universities supplement growth. However, the factors hindering the growth of the market are reliability on grants and funding from the government and decrease in capital expenditure from academic institutions. Technological advancements opened new opportunities in the market.
Get full summary of the Report:- https://www.alliedmarketresearch.com/european-ngs-services-market
The key market player profiled in the report are Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina INC., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science. They have implemented strategies, such as merger & acquisitions, partnerships, agreements, and others to gain strong foothold in the market.
Request Sample Report:- https://www.alliedmarketresearch.com/request-toc-and-sample/907
KEY MARKET SEGMENTS
By Technology
- SBS
- Ion Semiconductor
- SBL
- Pyro-Sequencing
- SMRT
By Application
- Research applications
- Clinical applications
- Sequencing
- RNA-sequencing
- Targeted sequencing
- Exome sequencing
- Whole genome sequencing
- Chip-sequencing
- Methyl-sequencing
- De novo sequencing
- Others
By Disease Type
- Oncology
- Lung cancer
- Breast cancer
- Prostate cancer
- Colorectal cancer
- Others
By End User
- Research centres, academic & government institutes
- Hospitals & clinics
- Pharmaceutical & biotechnology companies
- Others
By Country
- U.K.
- Germany
- France
- Italy
- Spain
- Netherlands
- Rest of the Europe (RoE)
Key Market Players
- Beijing Genomics Institute (BGI)
- Cegat (Centre for Genomics and Transcriptomics) GMBH
- DNA Vision SA
- Eurofins Genomics Inc.
- Febit / Comprehensive Biomarker Center GMBH (CBC)
- Genomnia SRL
- Mina Inc.
- Macrogen Inc.
- Microsynth AG
- Seqomics
-Source Bio Science
Europe NGS Services Market - Opportunities and Forecasts, 2014 - 2022